Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.

Chinese journal of cancer - 8 Apr 2015

Zhang Jian-Wei, Qin Tao, Hong Shao-Dong, Zhang Jing, Fang Wen-Feng, Zhao Yuan-Yuan, Yang Yun-Peng, Xue Cong, Huang Yan, Zhao Hong-Yuan, Ma Yu-Xiang, Hu Zhi-Huang, Huang Pei-Yu, Zhang Li

Abstract excerpt

INTRODUCTION: An increasing number of targeted drugs have been tested for the treatment of nasopharyngeal carcinoma (NPC). However, targeted therapy-related oncogenic mutations have not been fully evaluated. This study aimed to detect targeted therapy-related oncogenic mutations in NPC and to determine which targeted therapy might be potentially effective in treating NPC. METHODS: By using the SNaPshot assay, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nasopharyngeal Carcinoma

Share to Nasopharyngeal Neoplasms

Share to Neoplasm Recurrence, Local

Share to Oncogenes

Share to Pharmacogenetics

Share to Phosphatidylinositol 3-Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 25963410
DOI: 10.1186/s40880-015-0011-0
PMCID: PMC4593383

Genes

EGFR
BRAF
KIT
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.PMID 25963410Read ↗

Oncogene mutational profile in nasopharyngeal carcinomaSemantic proximity Read ↗

Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma.Semantic proximity Read ↗

The genomic landscape of nasopharyngeal carcinoma.Semantic proximity Read ↗

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay.Semantic proximity Read ↗

Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.Semantic proximity Read ↗

Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challengesSemantic proximity Read ↗

Investigational drugs for nasopharyngeal carcinoma.Semantic proximity Read ↗

Relationship of PI3K-Akt/mTOR/AMPK signaling pathway genetic mutation with efficacy and prognosis in nasopharyngeal carcinoma.Semantic proximity Read ↗

C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines.Semantic proximity Read ↗

VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinomaSemantic proximity Read ↗

Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.